Jendrzejewski et al. showed that this variant modulates PTCSC3 expression, a thyroid-specific tumor suppressor strongly downregulated in tumors, especially in T allele carriers [60], and meta-analyses confirmed its association with PTC risk [61,62,63,64]. This evidence concerns the gene PTCSC3 and neoplasm.